Meridian Bioscience's $1.53B Sale Clears Antitrust Hurdles
Meridian Bioscience Inc. told investors Tuesday that its proposed $1.53 billion sale to SD Biosensor Inc. and SJL Partners LLC has received several key antitrust approvals and is still on track...To view the full article, register now.
Already a subscriber? Click here to view full article